Arya Health is a technology company.
Arya Health provides digital agents that automate healthcare front office tasks, enhancing efficiency and productivity for healthcare operators.
Arya Health has raised $25.0M across 3 funding rounds.
Arya Health has raised $25.0M in total across 3 funding rounds.
# High-Level Overview
Arya Health operates as a dual-focused healthcare technology company serving two distinct markets with AI-powered automation solutions. The company has two primary product lines: an EMR (electronic health record) system designed for primary care clinics across Canada[1], and an AI-native workforce automation platform targeting post-acute care providers in the United States[3][4].
For Canadian clinics, Arya provides a comprehensive EMR solution with integrated telehealth, billing, patient portals, and analytics capabilities[1]. For U.S. post-acute care organizations (home care, skilled nursing facilities), Arya deploys AI-powered "digital agents" that automate administrative functions like scheduling, payroll, compliance tracking, and staff onboarding[3][4]. The company addresses a critical pain point: post-acute care organizations spend approximately 25 cents of every dollar on non-clinical administrative tasks[3], diverting resources from patient care and caregiver support.
# Origin Story
Arya Health was founded in 2018 as a Vancouver-based healthcare technology company[2]. The EMR product was built by physicians for physicians, reflecting the founders' deep understanding of clinical workflows[1]. The company has since expanded significantly, with the post-acute care automation division emerging as a major growth driver. By October 2025, Arya announced an $18.2 million Series A funding round, bringing total funding to $25 million[3]. The company has demonstrated explosive growth, expanding more than six times in 2025 and tracking toward 10x year-over-year growth by year-end[3].
# Core Differentiators
# Role in the Broader Tech Landscape
Arya is positioned at the intersection of two major healthcare trends: digital transformation of clinical workflows and AI-driven automation of administrative burden. The healthcare industry faces a critical staffing crisis and administrative inefficiency—particularly acute in post-acute care, where labor costs and compliance complexity are escalating[3]. Arya's timing is strategic: as healthcare organizations face pressure to do more with fewer resources, AI agents that can autonomously handle repetitive administrative work offer immediate economic value without requiring organizational restructuring.
The company also reflects a broader shift in healthcare IT from monolithic, difficult-to-implement systems toward modular, AI-native platforms that integrate with existing infrastructure[4]. By positioning its agents as complementary to existing EMRs rather than replacements, Arya avoids the costly migration friction that has historically slowed healthcare software adoption.
# Quick Take & Future Outlook
Arya Health is executing a two-market strategy that leverages complementary strengths: the Canadian EMR business provides recurring revenue and clinical credibility, while the U.S. post-acute care automation platform represents the higher-growth opportunity. The $18.2 million Series A and appointment of experienced healthcare operators suggest the company is scaling aggressively toward market leadership in workforce automation.
The next phase will likely involve expanding the agent ecosystem beyond staffing, payroll, and compliance into additional administrative functions, deepening integrations with major EMR platforms, and potentially pursuing acquisitions to accelerate market consolidation. As healthcare organizations increasingly adopt AI-driven automation, Arya's early-mover advantage in purpose-built agents for post-acute care positions it to capture significant market share in a sector desperate for operational efficiency solutions.
Arya Health has raised $25.0M in total across 3 funding rounds.
Arya Health's investors include ACME Capital, Bling Capital, Tiffany, Twelve Below.
Arya Health has raised $25.0M across 3 funding rounds. Most recently, it raised $18.0M Series A in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2025 | $18.0M Series A | ACME Capital, Bling Capital, Tiffany, Twelve Below | |
| Sep 1, 2024 | $4.0M Seed | Bling Capital, Tiffany, Twelve Below | |
| Jun 1, 2022 | $3.0M Seed | Bling Capital, Tiffany, Twelve Below |